• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medication during pregnancy and breastfeeding is challenging for women with the condition. There aren't many studies regarding how exposure over time may affect the pregnant fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medication need to consider the benefits of taking it against the possible risks for the baby. The doctors don't have the information to make unambiguous recommendations however they can provide information on the risks and benefits to aid pregnant women in making informed decisions.

A study published in Molecular Psychiatry concluded that women who were taking adhd medication cost medication during their early pregnancy were not at greater risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based case control study to examine the prevalence of major structural defects in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure correct classification of the cases and to reduce the possibility of bias.

However, the study had its limitations. The researchers were unable, in the first place to distinguish the effects triggered by the medication from the disorder. This limitation makes it difficult for researchers to determine if the few associations observed between the exposed groups were due to the use of medication or if they were affected by comorbidities. Additionally, the researchers did not examine the long-term outcomes of offspring.

The study found that infants whose mothers had taken mild adhd medication medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) as compared to mothers who did not use any medication during pregnancy or quit taking the medication prior to or during pregnancy. This was due to central nervous system-related disorders, and the increased risk for admission was not found to be influenced by which stimulant medications were taken during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases appear to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the minor risk of using ADHD medication during pregnancies in the early stages can be offset by greater benefits to both mother and baby from continuing treatment for the woman’s disorder. Physicians should discuss this with their patients and, where possible, help them develop strategies to improve coping skills that may minimize the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and treated with medication, the question of whether or not to stop treatment during pregnancy is one that doctors are having to have to face. Often, these decisions are made in the absence of any evidence that is clear and definitive in either case, which means that doctors must weigh what they know, the experiences of other doctors, and what research suggests on the subject, along with their own judgments for each individual patient.

The issue of potential risks to the infant can be extremely difficult. The research on this issue is based on observations rather than controlled studies, and the results are in conflict. In addition, most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could lead to abortion or termination of the pregnancy. The study that is discussed in the journal club addresses these limitations, by examining both information on deceased and live births.

Conclusion Some studies have shown a positive correlation between ADHD medications and certain birth defects However, other studies haven't found a correlation. Most studies have shown an unintended, or slight negative effect. Therefore, a careful risk/benefit analysis is required in every case.

It can be difficult, if not impossible, for women suffering from ADHD to stop taking their medication. In fact, in an article published in Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness and family conflict for these patients. A loss of medication may affect the ability to drive safely and to perform work-related tasks which are crucial aspects of daily life for those with ADHD.

She recommends women who are unsure about whether to keep or stop taking medication because of their pregnancy consider informing family members, friends and colleagues on the condition, its effects on daily functioning, and on the advantages of staying on the current treatment plan. In addition, educating them can make the woman feel more comfortable in her struggle with her decision. It is also worth noting that some drugs can adhd medication help with memory (Www.cheaperseeker.com) pass through the placenta so if a woman decides to stop her ADHD medication during pregnancy and breastfeeding, she should be aware that traces of the drug can be transferred to the child.

Risk of Birth Defects

As the use and use of ADHD medications to treat the symptoms of attention deficit disorder hyperactivity disorder (ADHD) is increasing the concern over the potential adverse effects of the drugs on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Researchers used two huge data sets to study more than 4.3 million pregnancies and determine if the use of stimulant medications increased the risk of birth defects. Researchers discovered that, while the risk overall is low, first-trimester ADHD medication exposure was associated with slightly higher risk of certain heart defects, like ventriculoseptal defects.

The researchers behind the study found no association between early medication use and other congenital anomalies, like facial clefting, or club foot. The findings are in line with previous studies that have shown a small but significant increase in the risk of developing cardiac malformations in women who started taking ADHD medications prior to the time of the time of pregnancy. The risk was higher in the latter half of pregnancy, when a lot of women begin to discontinue their ADHD medication.

Women who used ADHD medications during the first trimester of their pregnancies were also more likely to undergo caesarean sections, a low Apgar score after delivery and a baby who needed breathing assistance at birth. The authors of the study could not eliminate bias due to selection because they restricted the study to women with no other medical conditions that could have contributed to the findings.

Researchers hope that their study will help doctors when they encounter pregnant women. The researchers suggest that, while discussing the risks and benefits are important, the decision on whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also caution that while discontinuing the medications is an option, it is not an option to consider due to the high incidence of depression and other mental health problems among women who are pregnant or who are recently postpartum. Research has also shown that women who stop taking their medication will have a tough transitioning to life without them after the baby is born.

Nursing

It can be a challenge becoming a mother. Women who suffer from ADHD can face severe challenges when they must manage their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to new routines. This is why many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The risk to breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk at a low level. However, the amount of medication exposure to the newborn may differ based on dosage, how often it is administered, and the time of day it is administered. Additionally, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn infant is not well known.

Some doctors may decide to stop stimulant medication during a woman's pregnancy due to the lack of research. This is a difficult decision for the patient, who must balance the benefits of continuing her medication against the potential risks to the embryo. In the meantime, until more information is available, doctors should ask all pregnant patients about their history of ADHD and if they are planning or taking to take medication during the perinatal period.

A increasing number of studies have proven that most women can safely continue taking their ADHD medication during pregnancy and breastfeeding. In the end, an increasing number of patients choose to do so and in consultation with their doctor they have discovered that the benefits of continuing their current medication far outweigh any risks.

It is crucial for women suffering from ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non prescription adhd medication-pharmacological strategies. Psychoeducation is also needed to help pregnant women with adhd treatment medication recognize the signs and underlying disorder. They should also learn about treatment options and strengthen coping mechanisms. This should be a multidisciplinary process including obstetricians, GPs and psychiatry. Pregnancy counselling should include discussion of a management plan for both mother and child, as well as monitoring for signs of deterioration, and the need for adjustments to the medication regimen.